DSM to acquire human milk oligosaccharides supplier for $827m
date:Feb 25, 2020
Ms broad global customer base and integrate it in its full solutions offering for Infant Nutrition customers, but it also creates leverage with DSMs strong RD platform and clinical competencies to support the development of Glycoms next-generation HMOs. DSM is a real great home for Glycom to reach its full potential.

The deal is expected to complete in the second quarter of this year.

4/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/25 14:45